Clinical trials: Rectal Gonorrhea
Gonorrhoea of Rectum, Chlamydia of Rectum
STI Screening as a Combined HIV Prevention Platform for MSM in Peru
The investigators propose to develop and pilot an HIV prevention intervention based on rectal STI testing, counseling, and treatment for MSM in Peru.
- Conditions
- Gonorrhoea of Rectum, Chlamydia of Rectum, HIV Infections
- Trial name
- NCT03010020
- Testing
- PCC, Traditional Counseling
- Where
- Peru
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- University of California, Los Angeles
Chlamydia Infections, Gonorrhea
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections
Investigators at the University of Alabama in Birmingham in collaboration with investigators from the Centers for Disease Control in Atlanta are evaluating the performance of three commercial nucleic acid amplification tests for…
- Trial name
- NCT00252096
- Testing
- Nucleic acid amplification test
- Where
- United States
- Volunteers
- 3,900 people
- Sponsor
- Centers for Disease Control and Prevention
Gonorrhea, Chlamydia
Cepheid Rectal Sample Validation Study
The purpose of this study is to validate Xpert CT/NG for the detection of CT and GC in rectal samples as part of the PA DOH and CLIA requirements.
- Conditions
- Gonorrhea, Chlamydia, Trichomonas
- Trial name
- NCT02099760
- Testing
- STD testing (GC/Ct/trich)
- Where
- 2 sites in United States
- Volunteers
- 402 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh
Gonorrhea, Chlamydia
A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples
Our hypothesis is that nucleic acid amplification testing (NAAT) with the APTIMA Combo2 (AC2) will have greater sensitivity than culture in detecting Neisseria gonorrhoeae in rectal samples.
- Trial name
- NCT00827697
- Testing
- Gen-Probe APTIMA Combo2 (AC2)
- Where
- 2 sites in United States
- Volunteers
- 399 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh
Methamphetamine-dependence, Rectal Gonorrhea
Inflammation in Methamphetamine and STIs (IMSTI)
This clinical trial aims to investigate the effects of a decline in methamphetamine use on rectal inflammatory cytokine levels, substance use contexts, and HIV/STI risk behavior.
- Conditions
- Methamphetamine-dependence, Rectal Gonorrhea, Rectal Chlamydia
- Trial name
- IMSTI (NCT05162391)
- Testing
- Contingency Management
- Where
- United States
- Volunteers
- 59 people, healthy volunteers welcome
- Sponsor
- University of California, Los Angeles
Gonorrhea
Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea
A non-inferiority, open-label, multicentre randomised controlled trial to compare two therapeutic regimens for the treatment of uncomplicated urogenital, rectal or pharyngeal gonorrhoea in men and women between 18 and 75 years of…
- Trial name
- NCT06090565
- Testing
- Cefixime, Doxycyclin, Ceftriaxon
- Where
- 2 sites in Czechia
- Volunteers
- 161 people
- Sponsor
- Bulovka Hospital
HIV, Gonorrhea
Improving Clinic Delivery of HIV-related Anal Health Services
This project will test ways to reduce stigma in healthcare settings so that more providers offer, and more patients receive, important anal sex-related HIV services, including anorectal sexually transmitted infection (STI)…
- Conditions
- HIV, Gonorrhea, Chlamydia, Anal Cancer Squamous Cell
- Trial name
- PEACHES 2 (NCT07464236)
- Testing
- PEACHES 2.0 Implementation Strategies
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Albert Einstein College of Medicine